Trials / Completed
CompletedNCT00399568
Efficacy and Safety of Intravenous Acetaminophen Over 48 Hrs for the Treatment of Post-op Pain After Gynecologic Surgery
Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel, Multiple-Dose Study of the Analgesic Efficacy and Safety of IV Acetaminophen (APAP) Versus Placebo Over 48 Hours(Hrs) for the Treatment of Postoperative Pain After Gynecologic Surgery
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 331 (actual)
- Sponsor
- Mallinckrodt · Industry
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study will be investigating the efficacy and safety administration of multiple doses of intravenous (IV) acetaminophen (IVAPAP) in the 48 hour period following Gynecologic Surgery.
Detailed description
The research hypothesis is that IV Acetaminophen will provide greater reduction in pain intensity and greater pain relief for moderate and severe pain as compared to placebo in the 48 hours following surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IV Acetaminophen | Intravenous acetaminophen 1 g/100 mL |
| DRUG | IV Placebo 100 mL solution | IV Placebo 100 mL solution dosed at same frequency as IV Acetaminophen every 6 hours (q6h) |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2007-09-01
- Completion
- 2007-09-01
- First posted
- 2006-11-15
- Last updated
- 2016-10-21
- Results posted
- 2010-12-10
Locations
27 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00399568. Inclusion in this directory is not an endorsement.